These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19884478)

  • 1. Letter by Barrios et al regarding article, "Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study".
    Barrios V; Escobar C; Echarri R
    Circulation; 2009 Nov; 120(18):e153; author reply e154. PubMed ID: 19884478
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
    Go AS; Fang MC; Udaltsova N; Chang Y; Pomernacki NK; Borowsky L; Singer DE;
    Circulation; 2009 Mar; 119(10):1363-9. PubMed ID: 19255343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thromboembolism risks in atrial fibrillation].
    Babuty D; Gorin L; Zannad N; Fauchier L
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S11-3. PubMed ID: 20103170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and atherothrombosis: the importance of anticoagulation.
    Escobar C; Barrios V
    Am Heart J; 2009 May; 157(5):e27; author reply e29. PubMed ID: 19376295
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter regarding article by Gage et al, "selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin".
    Boyajian RA; Otis SM
    Circulation; 2005 Jun; 111(25):e455-6; author reply e455-6. PubMed ID: 15983256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of thromboembolism in non-valvular atrial fibrillation].
    Coccheri S; Cosmi B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):927-9. PubMed ID: 12497850
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation between kidney function, proteinuria, and adverse outcomes--a critical look at the application of medical statistics in the Nephrology literature.
    Onuigbo MA
    QJM; 2010 Jul; 103(7):537-8. PubMed ID: 20385569
    [No Abstract]   [Full Text] [Related]  

  • 9. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.
    Watanabe H; Watanabe T; Sasaki S; Nagai K; Roden DM; Aizawa Y
    Am Heart J; 2009 Oct; 158(4):629-36. PubMed ID: 19781424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation.
    McLeod CJ; Gersh BJ
    Arch Intern Med; 2009 Nov; 169(21):2032-3; author reply 2033. PubMed ID: 19933968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Why is it that "only" women with chronic non-valvular atrial fibrillation older than 75 years of age are at higher thromboembolic risk?].
    Lovreglio V
    Ital Heart J Suppl; 2000 Aug; 1(8):1078-9. PubMed ID: 10993024
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
    Watson T; Shantsila E; Lip GY
    Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter 2: Prevention of perioperative thromboembolism in patients with atrial fibrillation (Br J Surg 2007; 94: 1351-1355).
    Potter J
    Br J Surg; 2008 Mar; 95(3):399-400; author reply 400. PubMed ID: 18278793
    [No Abstract]   [Full Text] [Related]  

  • 14. The risks of lone atrial fibrillation.
    N Engl J Med; 1988 Mar; 318(10):639-40. PubMed ID: 3344010
    [No Abstract]   [Full Text] [Related]  

  • 15. [Atrial fibrillation and chronic kidney disease].
    Dąbrowski P; Mizia-Stec K; Chudek J
    Kardiol Pol; 2011; 69(2):167-72. PubMed ID: 21332063
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on the article by Vázquez and Márquez-Garcia. High-risk vs. low-risk for thrombo-embolic events: who are in the intermediate-risk group? What should be done then?
    Benchimol-Barbosa PR; Barbosa-Filho J
    Int J Cardiol; 2008 Mar; 124(3):358-9; author reply 360-1. PubMed ID: 17400310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between decreased glomerular filtration rate and nonvalvular atrial fibrillation.
    Balta S; Demirkol S; Arslan Z; Sahin MA; Yesil FG; Kucuk U
    Cardiology; 2013; 124(4):219. PubMed ID: 23548826
    [No Abstract]   [Full Text] [Related]  

  • 18. D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism?
    Cohen A; Ederhy S; Meuleman C; Di Angelantonio E; Dufaitre G; Boccara F
    Eur Heart J; 2007 Sep; 28(18):2179-80. PubMed ID: 17716992
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of asymptomatic atrial fibrillation.
    Newell A; Haynes J; Smith R
    Am Fam Physician; 2012 Sep; 86(6):Online. PubMed ID: 23062052
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of the chronic kidney disease epidemiology collaboration equation and global cardiovascular risk assessment in patients with atrial fibrillation.
    Providência R; Barra S; Paiva L; Faustino A
    Cardiology; 2013; 124(4):220-1. PubMed ID: 23548844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.